[Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption]. 1985

V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster

It was shown that when the filtration capacity of the kidneys was lowered even insignificantly (the creatinine clearance 50-80 ml/min), the maximum blood levels of ampicillin increased 2 times and its retention time was prolonged. At the terminal stage of chronic renal insufficiency the half-life of the drug and the area under the pharmacokinetic curve markedly increased and the plasma clearance decreased. Hemodialysis and hemosorption significantly lowered the ampicillin half-life. The ampicillin coefficient in hemosorption was 2 times higher than that in hemodialysis.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
January 1979, Therapie,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
December 1994, The American journal of cardiology,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
November 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
May 1985, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
January 2012, La Revue du praticien,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
January 1991, La Revue de medecine interne,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
January 1986, Urologiia i nefrologiia,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
January 1994, Gaceta medica de Mexico,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
June 1987, Pathologie-biologie,
V P Iakovlev, and L Z Skala, and V L Cherniakov, and V A Shcherbakov, and A M Shuster
March 1986, Revista medica de Chile,
Copied contents to your clipboard!